{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:08Z","timestamp":1753890608818,"version":"3.41.2"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>This viewpoint report describes how the evolution of transcatheter mitral valve intervention (TMVI) is influenced by lessons learned from three evolutionary tracks: (1) the development of treatment from mitral valve surgery (MVS) to transcutaneous procedures; (2) the evolution of biomedical engineering for research and development resulting in predictable and safe clinical use; (3) the adaptation to local conditions, impact of transcatheter aortic valve replacement (TAVR) experience and creation of infrastructure for skills development and risk management. Thanks to developments in computer science and biostatistics, an increasing number of reports regarding clinical safety and effectiveness is generated. A full toolbox of techniques, devices and support technology is now available, especially in surgery. There is no doubt that the injury associated with a minimally invasive access reduces perioperative risks, but it may affect the effectiveness of the treatment due to incomplete correction. Based on literature, solutions and performance standards are formulated with an emphasis in technology and positive outcome. Despite references to Heart Team decision making, boundary conditions such as hospital infrastructure, caseload, skills training and perioperative risk management remain underexposed. The role of Biomedical Engineering is exclusively defined by the Research and Development (R&amp;amp;D) cycle including the impact of human factor engineering (HFE). Feasibility studies generate estimations of strengths and safety limitations. Usability testing reveals user friendliness and safety margins of clinical use. Apart from a certification requirement, this information should have an impact on the definition of necessary skills levels and consequent required training. Physicians Preference Testing (PPT) and use of a biosimulator are recommended. The example of the interaction between two Amsterdam heart centers describes the evolution of a professional ecosystem that can facilitate innovation. Adaptation to local conditions in terms of infrastructure, referrals and reimbursement, appears essential for the evolution of a complete mitral valve disease management program. Efficacy of institutional risk management performance (IRMP) and sufficient team skills should be embedded in an appropriate infrastructure that enables scale and offers complete and safe solutions for mitral valve disease. The longstanding evolution of mitral valve therapies is the result of working devices embedded in an ecosystem focused on developing skills and effective risk management actions.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1101337","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T20:55:22Z","timestamp":1689972922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The evolution of technical prerequisites and local boundary conditions for optimization of mitral valve interventions\u2014Emphasis on skills development and institutional risk performance"],"prefix":"10.3389","volume":"10","author":[{"given":"Riccardo","family":"Cocchieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertus","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Jan","family":"Baan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Riezebos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd","family":"van Tuijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas","family":"de Mol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ehf2.12677","article-title":"Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature","volume":"7","author":"Wierda","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41569-020-0395-7","article-title":"Mitral valve regurgitation: a disease with a wide spectrum of therapeutic options","volume":"17","author":"Del Forno","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ejcts\/ezy306","article-title":"Mitral valve modelling and three-dimensional printing for planning and simulation of mitral valve repair","volume":"55","author":"Daemen","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"850700","DOI":"10.3389\/fcvm.2022.850700","article-title":"State-of-the-art review: technical and imaging considerations in novel transapical and port-access mitral valve chordal repair for degenerative mitral regurgitation","volume":"9","author":"Hegeman","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1522-2942(07)70078-8","article-title":"Operative approaches to the left atrium and mitral valve: an update","volume":"3","author":"Pezzella","year":"1998","journal-title":"Oper Tech Thorac Cardiovasc Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jtcvs.2020.05.041","article-title":"Treatment options for ischemic mitral regurgitation: a meta-analysis","volume":"163","author":"Nappi","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.21037\/jtd.2018.07.07","article-title":"Functional mitral regurgitation: an overview for surgical management framework","volume":"10","author":"Nappi","year":"2018","journal-title":"J Thorac Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccl.2021.01.001","article-title":"Advances in mitral valve repair for degenerative mitral regurgitation: philosophy, technical details, and long-term results","volume":"39","author":"Del Forno","year":"2021","journal-title":"Cardiol Clin"},{"key":"B10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/17434440.2021.1894925","article-title":"Mitral valve surgery: current status and future prospects of the minimally invasive approach","volume":"18","author":"Van Praet","year":"2021","journal-title":"Expert Rev Med Devices"},{"key":"B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/eurheartj\/ehs248","article-title":"Mitral valve surgery: wait and see vs. Early operation","volume":"34","author":"De Bonis","year":"2013","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12471-020-01452-8","article-title":"Heart teams in The Netherlands: from teamwork to data-driven decision-making","volume":"28","author":"Wierda","year":"2020","journal-title":"Neth Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/ejcts\/ezab065","article-title":"Effect of a dedicated mitral heart team compared to a general heart team on survival: a retrospective, comparative, non-randomized interventional cohort study based on prospectively registered data","volume":"60","author":"Nia P","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/ejhf.1850","article-title":"Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results","volume":"22","author":"Adamo","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/ejhf.1774","article-title":"The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation","volume":"22","author":"Reichart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1002\/ehf2.13558","article-title":"Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation","volume":"8","author":"Truong","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.amjcard.2017.08.022","article-title":"Comparison of outcome after percutaneous mitral valve repair with the MitraClip in patients with versus without atrial fibrillation","volume":"120","author":"Velu","year":"2017","journal-title":"Am J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jamacardio.2019.4428","article-title":"Association of pulmonary hypertension with clinical outcomes of transcatheter mitral valve repair","volume":"5","author":"Al-Bawardy","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.jacc.2020.09.604","article-title":"Implications of elevated pulmonary artery pressure for transcatheter mitral repair: time for comprehensive hemodynamic investigation","volume":"76","author":"Opotowsky","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/jcm10051006","article-title":"Prognostic role of TAPSE to PASP ratio in patients undergoing MitraClip procedure","volume":"10","author":"Trejo-Velasco","year":"2021","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/jcm9061792","article-title":"Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: a real-life propensity-score matched study","volume":"9","author":"Pascual","year":"2020","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjcard.2020.03.045","article-title":"Left ventricular end-systolic dimension and outcome in patients with heart failure undergoing percutaneous MitraClip valve repair for secondary mitral regurgitation","volume":"126","author":"Debonnaire","year":"2020","journal-title":"Am J Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.4244\/EIJ-D-18-0087","article-title":"Impact of mitral valve treatment choice on mortality according to aetiology","volume":"14","author":"Kortlandt","year":"2019","journal-title":"EuroIntervention"},{"key":"B26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jcin.2014.01.171","article-title":"Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients","volume":"7","author":"Swaans","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1056\/NEJMe1812279","article-title":"Percutaneous repair of secondary mitral regurgitation\u2014A tale of two trials","volume":"379","author":"Nishimura","year":"2018","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/acs-2020-mv-24","article-title":"An updated meta-analysis of MitraClip versus surgery for mitral regurgitation","volume":"10","author":"Oh","year":"2021","journal-title":"Ann Cardiothorac Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.athoracsur.2021.07.030","article-title":"Transcatheter mitral valve therapy in the United States: a report from the STS\/ACC TVT registry","volume":"113","author":"Mack","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.109.849885","article-title":"Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON mitral annuloplasty device European union study","volume":"120","author":"Schofer","year":"2009","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.jcin.2016.07.005","article-title":"Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the cardioband percutaneous mitral repair system","volume":"9","author":"Nickenig","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1002\/ehf2.13301","article-title":"Effect of carillon mitral contour system on patient-reported outcomes in functional mitral regurgitation: an individual participant data meta-analysis","volume":"8","author":"Khan","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/eurheartj\/ehy594","article-title":"Cardioband to treat functional mitral regurgitation: a word of caution","volume":"40","author":"Carrel","year":"2019","journal-title":"Eur Heart J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.jacc.2021.08.060","article-title":"2-Year Outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation","volume":"78","author":"Muller","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.jcin.2021.06.014","article-title":"Randomized trials are needed for transcatheter mitral valve replacement","volume":"14","author":"Rogers","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/jocs.15995","article-title":"Transcatheter mitral valve therapies: state of the art","volume":"37","author":"Yousef","year":"2022","journal-title":"J Card Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1016\/j.jacc.2021.04.051","article-title":"Current status and future prospects of transcatheter mitral valve replacement: jACC state-of-the-art review","volume":"77","author":"Alperi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.31083\/j.rcm2303088","article-title":"Learning from controversy and revisiting the randomized trials of secondary mitral regurgitation","volume":"23","author":"Fiore","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/jcdd9080261","article-title":"At the crossroads of minimally invasive mitral valve surgery-benching single hospital experience to a national registry: a plea for risk management technology","volume":"9","author":"Cocchieri","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijcard.2021.05.002","article-title":"Accuracy of three-dimensional computational modeling in prediction of the dynamic neo left ventricular outflow tract with transcatheter mitral valve replacement","volume":"336","author":"Ooms","year":"2021","journal-title":"Int J Cardiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1053\/j.semtcvs.2019.01.008","article-title":"Mathematical blueprint of a mitral valve","volume":"31","author":"Park","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0130906","DOI":"10.1371\/journal.pone.0130906","article-title":"Personalized computational modeling of mitral valve prolapse: virtual leaflet resection","volume":"10","author":"Rim","year":"2015","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11548-019-01998-y","article-title":"Dynamic, patient-specific mitral valve modelling for planning transcatheter repairs","volume":"14","author":"Ginty","year":"2019","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"759675","DOI":"10.3389\/fcvm.2021.759675","article-title":"Mitral valve atlas for artificial intelligence predictions of MitraClip intervention outcomes","volume":"8","author":"Dabiri","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1136\/heartjnl-2021-319725","article-title":"Artificial intelligence for the echocardiographic assessment of valvular heart disease","volume":"108","author":"Nedadur","year":"2022","journal-title":"Heart"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.athoracsur.2020.12.032","article-title":"Initial clinical experience with mitral valve translocation for secondary mitral regurgitation","volume":"112","author":"Gammie","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"ezac135","DOI":"10.1093\/ejcts\/ezac135","article-title":"Commissural closure to treat severe mitral regurgitation: standing the test of time","volume":"62","author":"Carino","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"B50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.athoracsur.2020.04.112","article-title":"Development of a reproducible swine model of chronic ischemic mitral regurgitation: lessons learned","volume":"111","author":"Pasrija","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e001010","DOI":"10.1161\/JAHA.114.001010","article-title":"Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation","volume":"3","author":"Naji","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B52","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10554-018-1507-x","article-title":"Can stress echocardiography identify patients who will benefit from percutaneous mitral valve repair?","volume":"35","author":"Velu","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"B53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ahj.2019.12.022","article-title":"Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: results from the German TRAnscatheter mitral valve interventions (TRAMI) registry","volume":"222","author":"Kalbacher","year":"2020","journal-title":"Am Heart J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jtcvs.2019.10.193","article-title":"Body mass index and early outcomes following mitral valve surgery for degenerative disease","volume":"161","author":"Burns","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jns.2017.10.004","article-title":"Carotid artery stenosis as an independent risk factor for perioperative strokes following mitral valve surgical intervention","volume":"382","author":"Udesh","year":"2017","journal-title":"J Neurol Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/eurheartj\/ehv333","article-title":"Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium","volume":"36","author":"Stone","year":"2015","journal-title":"Eur Heart J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e001393","DOI":"10.1136\/openhrt-2020-001393","article-title":"Minimally invasive mitral valve surgery: a systematic safety analysis","volume":"7","author":"Ko","year":"2020","journal-title":"Open Heart"},{"key":"B59","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.surg.2016.08.017","article-title":"Failure-to-rescue after injury is associated with preventability: the results of mortality panel review of failure-to-rescue cases in trauma surgery","volume":"161","author":"Kuo","year":"2017","journal-title":"Surgery"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.athoracsur.2021.06.025","article-title":"Failure to rescue: a new society of thoracic surgeons quality metric for cardiac surgery","volume":"113","author":"Kurlansky","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.3390\/jcm10173877","article-title":"The impact of biomedical engineering on the development of minimally invasive cardio-thoracic surgery","volume":"10","author":"Cocchieri","year":"2021","journal-title":"J Clin Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s43441-019-00022-4","article-title":"Impact of design on medical device safety","volume":"54","author":"Micl\u0103u\u015f","year":"2020","journal-title":"Ther Innov Regul Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/MDER.S368420","article-title":"Preference testing in medical devices: current framework and regulatory gaps","volume":"15","author":"Lewis","year":"2022","journal-title":"Med Devices (Auckl)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/bmjqs-2013-001812","article-title":"Human factors and ergonomics as a patient safety practice","volume":"23","author":"Carayon","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"B65","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1037\/amp0000444","article-title":"Bridging psychology and engineering to make technology work for people","volume":"74","author":"Roscoe","year":"2019","journal-title":"Am Psychol"},{"key":"B66","first-page":"298","article-title":"Usability validation of medical devices: issues in identifying potential use errors","volume":"234","author":"Schiro","year":"2017","journal-title":"Stud Health Technol Inform"},{"key":"B67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/03091902.2015.1132785","article-title":"An analytical approach to identifying potential use-related issues concerning a medical device under development","volume":"40","author":"Gupta","year":"2016","journal-title":"J Med Eng Technol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"544","DOI":"10.21037\/acs.2016.03.16","article-title":"Robotic mitral valve surgery: overview, methodology, results, and perspective","volume":"5","author":"Chitwood","year":"2016","journal-title":"Ann Cardiothorac Surg"},{"key":"B69","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/17434440.2021.1960506","article-title":"The role of robotic technology in minimally invasive surgery for mitral valve disease","volume":"18","author":"Bonatti","year":"2021","journal-title":"Expert Rev Med Devices"},{"key":"B70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.hlc.2019.05.170","article-title":"The future of open heart surgery in the era of robotic and minimal surgical interventions","volume":"29","author":"Harky","year":"2020","journal-title":"Heart Lung Circ"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/bmjsit-2019-000022","article-title":"Generating evidence for new high-risk medical devices","volume":"1","author":"Campbell","year":"2019","journal-title":"BMJ Surg Interv Health Technol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1017\/S0266462307051677","article-title":"Benefits of and barriers to involving users in medical device technology development and evaluation","volume":"23","author":"Shah","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"B73","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13239-020-00499-3","article-title":"First expert evaluation of a new steerable catheter in an isolated beating heart","volume":"11","author":"Ali","year":"2020","journal-title":"Cardiovasc Eng Technol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jtcvs.2018.09.014","article-title":"Development of a high-fidelity minimally invasive mitral valve surgery simulator","volume":"157","author":"Nia P","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1510\/mmcts.2018.045","article-title":"Beating heart porcine high-fidelity simulator for the training of edge-to-edge mitral valve repair","volume":"2018","author":"Gollmann-Tepek\u00f6yl\u00fc","year":"2018","journal-title":"Multimed Man Cardiothorac Surg"},{"key":"B76","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jtcvs.2017.09.011","article-title":"The dynamic cardiac biosimulator: a method for training physicians in beating-heart mitral valve repair procedures","volume":"155","author":"Leopaldi","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B77","doi-asserted-by":"publisher","first-page":"776","DOI":"10.21037\/acs.2018.10.01","article-title":"Early clinical results with the Tendyne transcatheter mitral valve replacement system","volume":"7","author":"Beller","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.jcin.2017.05.032","article-title":"2-Year outcomes after transcatheter mitral valve replacement","volume":"10","author":"Regueiro","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"B79","doi-asserted-by":"publisher","first-page":"862471","DOI":"10.3389\/fcvm.2022.862471","article-title":"Anatomy of a transcatheter mitral valve service","volume":"9","author":"Gill","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/ejcts\/ezw034","article-title":"First results of a national initiative to enable quality improvement of cardiovascular care by transparently reporting on patient-relevant outcomes","volume":"49","author":"Van Veghel","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"B81","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jacc.2009.03.077","article-title":"EVEREST Investigators percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (endovascular valve edge-to-edge REpair study) cohort","volume":"54","author":"Feldman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"E427","DOI":"10.1002\/ccd.29464","article-title":"Tricuspid regurgitation after transcatheter mitral valve repair: clinical course and impact on outcome","volume":"98","author":"Meijerink","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/ccd.27993","article-title":"Myocardial fibrosis predicts adverse outcome after MitraClip implantation","volume":"93","author":"Velu","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6587036","DOI":"10.1155\/2022\/6587036","article-title":"Transcatheter mitral valve replacement in high-surgical risk patients: a single-center experience and outcome","volume":"2022","author":"Taha","year":"2022","journal-title":"J. Interv Cardiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jcin.2021.10.018","article-title":"30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: intrepid TMVR early feasibility study results","volume":"15","author":"Zahr","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"B86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/bioengineering9060230","article-title":"Structural heart valve disease in the era of change and innovation: the crosstalk between medical sciences and engineering","volume":"9","author":"Nappi","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12471-019-1285-7","article-title":"Value of machine learning in predicting TAVI outcomes","volume":"27","author":"Lopes","year":"2019","journal-title":"Neth Heart J"},{"key":"B88","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ccd.30398","article-title":"Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on The Netherlands heart registration (NHR): the TAVI-NHR risk model","volume":"100","author":"Al-Farra","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1101337\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T20:55:26Z","timestamp":1689972926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1101337\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":89,"alternative-id":["10.3389\/fcvm.2023.1101337"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1101337","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"article-number":"1101337"}}